Automated Cell Counters Market Estimated To Witness High Growth Owing To Rising Prevalence Of Chronic And Infectious Diseases
Market Overview:
Automated cell counters are laboratory instruments used for rapidly counting and sizing of cells in a liquid sample. They automatically count cells and analyze parameters like cell size, cell volume, cell granularity and cell populations. These devices are used in diagnostics and research applications for blood analysis, food analysis, water quality testing, production of biotherapeutics and cell culture analysis. Cell counting plays an important role in disease diagnosis, treatment development and drug discovery research.
Market Dynamics:
The automated cell counters market is witnessing high growth owing to rising prevalence of chronic and infectious diseases globally. According to the World Health Organization (WHO), cardiovascular diseases are the number one cause of deaths globally, taking an estimated 17.9 million lives each year. Similarly, cancer claimed nearly 10 million lives in 2020. Proper disease diagnosis requires analyzing hematology parameters and cell counts which is fueling the demand for automated cell counters.
The second driver of the market is growing cell-based research activities. Cell culture is a widely used technique in regenerative medicine, biomanufacturing, toxicology testing and cancer drug discovery. Growing funding for cell-based research from both public and private organizations is leading to increased adoption of automated cell counters for cell counting applications in research laboratories.
The global Automated Cell Counters Market Growth is estimated to be valued at US$ 3.75 Bn in 2023 and is expected to exhibit a CAGR of 7.0% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
SWOT Analysis
Strength:
- Automated cell counters offer accurate, fast and reproducible cell counting compared to manual cell counting methods. Automated cell counters reduce errors and save time.
- These counters provide consistent cell analysis results with high precision across various cell types and samples.
- Automated cell counters enable high-throughput analysis of numerous samples in a short period of time.
Weakness:
- High initial investments are required for automated cell counters and related equipment and software.
- Regular maintenance, calibration and servicing of automated cell counters add to the operational costs.
Opportunity:
- Growing prevalence of chronic and infectious diseases is boosting cell-based research. This widens the scope for application of automated cell counters.
- Small and medium laboratories are investing in automated cell counters owing to rising demand for high-quality analysis.
Threats:
- Introduction of alternative techniques such as flow cytometry poses threat to the automated cell counters market.
- Economic slowdowns can reduce research budgets and affect the demand for automated cell counters.
Key Takeaways
The global automated cell counters market is expected to witness high growth, exhibiting CAGR of 7.0% over the forecast period, due to increasing research activities in the fields of immunology, oncology and stem cell therapy. The rising focus on developing advanced cell-based therapies and vaccines will propel the demand for automated cell counters in the coming years.
Regional analysis:
North America dominated the global automated cell counters market in 2023, accounting for over 35% share. Presence of major players and availability of funds for cell-based research are driving the North America market. Asia Pacific is identified as the fastest growing regional market, slated to exhibit a CAGR of around 8.5% during the forecast period. Increasing healthcare spending, expanding biotechnology industry and growing stem cell research in China and India are anticipated to fuel the APAC market.
Key players:
Key players operating in the automated cell counters market are Thermo Fisher Scientific, Danaher Corporation, Agilent Technologies, PerkinElmer Inc., Bio-Rad Laboratories, BD, Merck KGaA, Logos Biosystems, Corning Incorporated, Tecan, Sartorius AG. These players are focusing on new product launches and partnerships to consolidate their market position.
Read More: https://blogger-veritas.blogspot.com/2023/12/biosimilars-is-fastest-growing-segment.html
English
Arabic
Français
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian